A. Gedikbaşı

Most-cited papers

1. Late-onset TK2 deficiency in adults: Long-term clinical outcomes of deoxynucleoside therapy.

   H. Durmuş, A. Gedikbaşı, S. Ceylaner, A. Çakar +3 more

   2026Mitochondrion (Amsterdam. Print)1 citations

   Semantic Scholar

   Save

2. 3.105P Late-onset thymidine kinase 2 deficiency: clinical features and long-term response in adult patients receiving deoxynucleoside therapy

   H. Durmuş, A. Gedikbaşı, A. Çakar, E. Kıyan +1 more

   2026Neuromuscular Disorders0 citations

   Semantic Scholar

   Save

3. 333PLong-term follow-up deoxynucleoside therapy for late onset thymidine kinase 2 deficiency patients

   H. D. Tekce, A. Gedikbaşı, S. Ceylaner, A. Çakar +2 more

   2025Neuromuscular Disorders0 citations

   Semantic Scholar

   Save

4. Long-term Follow-up Deoxynucleoside Therapy for Late-onset Thymidine Kinase 2 Deficiency Patients (S21.004)

   H. Durmuş, A. Gedikbaşı, S. Ceylaner, E. Kıyan +1 more

   2024Neurology0 citations

   Semantic Scholar

   Save

5. 533P Long-term follow-up deoxynucleoside therapy for late onset thymidine kinase 2 deficiency patients

   H. Durmus, A. Gedikbaşı, S. Ceylaner, E. Kıyan +1 more

   2024Neuromuscular Disorders0 citations

   Semantic Scholar

   Save

6. P354 Deoxynucleoside therapy for late onset thymidine kinase 2 deficiency patients

   H. D. Tekce, A. Gedikbaşı, S. Ceylaner, H. Demirci +4 more

   2023Neuromuscular Disorders0 citations

   Semantic Scholar

   Save